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ABSTRACT 
 
Aim: This study is to evaluate the efficacy of dexmedetomidine and propofol as an appropriate sedative drug for 
monitored anaesthesia care in patients undergoing cataract surgery. Materials and methods: A total of 60 patients 
are being recruited into this study, Patients were randomized into 2 groups, as group D and group P to receive 
dexmedetomidine and propofol patients undergoing cataract surgery respectively. Results:. MAP, HR, RR, SPO2 
were compared between the 2 groups, group P and D at various time points from T1-T9 were found not to be 
statistically significant as p>0.05. ISAS of group D is 53.50 ±2.193 and ISAS of group P is 43.10 ±2.090. The p 
value between the 2 study groups is 0.0001 which is highly statistically significant. Ramsay sedation scale of 3 was 
maintained throughout the operation in both the study groups. Conclusion: The study showed that 
dexmedetomidine seems to be an acceptable agent for MAC compared to propofol in patients undergoing cataract 
surgery. Satisfaction scores are also in favor of the patients treated with dexmedetomidine. 
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Introduction 
 
Cataract surgery can be safely performed under 
monitored anaesthesia care (MAC) with or without 
local anaesthesia [1]. Several drugs such as propofol, 
benzodiazepines and opioids have been used for MAC 
either alone or in combination [2]. Benzodiazepines 
may cause excessive sedation and confusion especially 
in elderly patients[3], and propofol can also result in 
disorientation and excessive sedation. Because these 
drugs have no analgesic component topical local 
anaesthestics were often used to prevent the 
unintentional reflex to painful stimuli. Considering 
that, most of the patients undergoing cataract surgery 
are elderly; the above mentioned aspects can be serious 
potential problems. Based on the analysis of the 
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database, over dosage of sedative leading to respiratory 
depression was the most common (24%) in MAC 
claims and 40% of these resulted in permanent brain 
damage or death [4]. Dexmedetomidine is a novel 
selective α2 receptor agonist that produces sedation 
and analgesia without causing respiratory depression 
[5]. It also allows patients to respond to the verbal 
commands during sedation. It has been used in various 
clinical fields such as sedation in ICU, awake 
intubation, shockwave lithotripsy, endoscopic 
examination [6] and as an adjuvant to anaesthetics. The 
present study is undertaken to perform a controlled 
comparison and evaluation of efficacy of 
dexmedetomidine and propofol as an appropriate 
sedative drug for MAC in outpatients undergoing 
cataract surgery, which included a survey of patient’s 
satisfaction. 
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Materials and methods  
 
The study was approved by the Institutional Review 
Board and all the participants gave written informed 
consent for this study.  
Inclusion criteria:  20 and 75 years. They were 
American Society of Anaesthesiologists (ASA) 
classification I, II or III and scheduled for cataract 
surgery under MAC. 
Exclusion criteria: Pre-operative exclusion criteria 
were pregnancy, kidney or hepatic disease, chronic 
medication with analgesic or sedative drug, or history 
of alcohol or drug abuse. Patients were randomized to 
receive either dexmedetomidine (group D) or propofol 
(group P). Patients fasted at least 8 hours before the 
operation and did not receive any preoperative sedative 
drug. On arriving at the operating room, standard 
monitoring, including electrocardiography, non-
invasive arterial blood pressure cuff, and peripheral 
pulse oximetry were applied. Oxygen was administered 
via nasal cannula at 5 L/min. Topical anaesthesia using 
sterile 0.5% proparacaine hydrochloride ophthalmic 
solution was applied to the eye of patients. Patients of 
group D received 0.6 mcg/kg/h of dexmedetomidine, 
and patients of group P were given 2 mg/kg/h of 
propofol infusion over a period of 15 minutes before 
surgery respectively. Dexmedetomidine was diluted in 
2 mcg/ml in normal saline for group D, and 100 mg of 
propofol accounting to 10 ml volume for group P. Each 
drug was titrated every 5 min to Ramsay sedation scale 
3 during the operation. Administration of 
dexmedetomidine was adjusted by 0.1mcg/kg/h, and 
propofol was adjusted by 0.3 mg/kg/h respectively. 
Injection Ephedrine 5 mg was kept ready to be 
administered in case systolic blood pressure  decreased 
below 90 mmHg or 70% of the preoperative value. 
Injection Atropine 0.5 mg was kept ready to be 
administered in case heart rate (HR) decreased below 
40 beats/ min. The infusion was stopped at the end of 
the surgery in both groups. In the recovery center for 
outpatients, patients were asked to answer the 11 
questions of Iowa satisfaction with anaesthesia scale 
(ISAS) using a 6 point rating scale at least 1 hour after 
the operation. It was performed by one 
anaesthesiologist who was blinded to the group 
assignment. MAP, HR, RR, and peripheral oxygen 
saturation (SpO2) were recorded at each time point as 
follows; T1 = preoperative baseline, T2 = anaesthesia 
start, T3 and T4 = 5 and 10 min after anaesthesia, T5 = 
operation start, T6, T7, and T8 = 5, 10, and 15 min 
after operation, T9=postoperative value. Moreover, the 
incidence of adverse events including hypertension, 
hypotension, bradycardia (HR< 50 beats/min), 
respiratory depression (RR<10 breaths/min), and 
oxygen desaturation (SpO2<93%) were evaluated.  
 
Results 
 
A total of 60 patients were recruited in this study. After 
initiation of the study, 30 patients were assigned to 
group D and the other 30 patients were assigned to 
group P. The characters of subdivided groups found no 
significant differences between the two groups. Total 
anaesthesia time was 36.0 ± 6.1 min in group D and 
38.2 ± 7.3 min in group P, and operation time was 21.0 
± 5.6 min and 20.7 ± 5.1 min in group D and P, 
respectively.  
 
Table 1: Demographic distribution in present study 
Mean Age Distribution of study group 
           Parameter Drug N Mean Std  Deviation P value 
Age Dexmedetomidine 30 56.70 5.503 0.924 
Propofol 30 56.57 5.224 
Mean weight distribution of study group 
Weight Dexmedetomidine 30 63.63 8.479 0.689 
Propofol 30 64.63 10.669 
Mean ISAS Score distribution of study groups 
ISAS Score Dexmedetomidine 30 53.50 2.193 0.001 *S 
Propofol 30 43.10 2.090 
 
 It can be seen that the difference in mean age between the two study groups is not statistically significant. (p > 0.05) 
and it also shows the mean weight of both the study groups. It can be seen that the difference in the  mean weight 
between the two groups is not statistically significant.  ( p > 0.05) and it also shows the ISAS SCORE of both the 
study groups. It can be seen that the difference in ISAS SCORE between the two study groups is statistically 
significant. ( p < 0.05). 
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Figure 1: Shows the comparison of mean arterial pressure between both the groups 
 
Mean Arterial Pressures of both the study groups at various time points from T1 to T9. It can be seen that the 
difference in MAP between two study groups is not statistically significant. (p > 0.05). 
 
 
Figure 2: Comparison of mean heart rate between both the groups 
 
It can be seen that the heart rate difference between two study groups is not statistically significant (p>0.05). 
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It can be seen that the RR difference between the two study groups is not statistically significant. ( p >0.05 ). 
Figure 3: Comparison of mean respiratory rate between both the groups 
 
 
 
It can be seen that the saturation difference between the two study groups is not statistically significant. ( p >0.05 ). 
Figure 4 : Comparison of mean saturation between both the groups 
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Discussion 
 
Results suggest that dexmedetomidine is an effective 
and safe drug for MAC in outpatients undergoing 
cataract surgery. Many studies were undertaken 
comparing dexmedetomidine with propofol for short 
surgical procedures, day care surgeries under MAC. 
Supporting the present study is a study conducted by 
Nahs, Song IA et al[7] titled "Dexmedetomidine is 
effective for Monitored Anaesthesia care in outpatients 
undergoing cataract surgery". Postoperative ISAS was 
50.3 (6.2) in group D and 42.7 (8.7) in group P, which 
was statistically significant (P < 0.001). SBP was 
significantly lower in group D compared with group P 
from the beginning of the operation. HR, RR, and SpO2 
were comparable between the two groups. There were 
8 cases (25.8%) of hypertension in group P, and 1 case 
(3.2%) in group D (P < 0.05). In contrast, 1 case 
(3.2%) of hypotension and 1 case (3.2%) of 
bradycardia occurred in group D. This study concluded 
that, compared with combined use of propofol and 
alfentanil,  dexmedetomidine could be used 
appropriately for monitored anaesthesia care in cataract 
surgeries with better satisfaction from patients and 
more stable cardiovascular state. Another study by 
G.Harinath et al[8] was conducted for a period of 1 
year on 60 patients with age groups 20-50 years both 
males and females, belonging to ASA I and II, 
undergoing short surgical procedures. Patients were 
divided into two groups. Group-1 received injection 
fentanyl and injection dexmedetomidine, group-2 
received injection fentanyl and injection propofol. 
Comparing both the drugs for short surgical 
procedures, showed that onset of sedation time longer 
in D group (26.8Vs16.7 p<0.01) .However, there was 
no significant difference in the Ramsay sedation score 
levels throughout the sedation period in both groups. In 
the recovery room, it was found that the time to 
achieve an Aldrete score of 10 was similar in both 
groups. Therefore dexmedetomidine can be a useful 
adjuvant rather than the single sedative analgesic 
during short surgeries and can be an alternative to 
propofol for moderate sedation with haemodynamic 
stability and with minimal side effects. Previous 
studies have reported that dexmedetomidine can also 
be used effectively in cataract surgery. Ayoglu et al [9] 
demonstrated that intraocular pressure was decreased 
and satisfactory sedation and analgesia were achieved 
by a sole loading infusion of 1 mcg/kg 
dexmedetomidine for 10 min preoperatively.When 
additional sedation was needed, dexmedetomidine 2 
mcg/ml for patient-controlled sedation (PCS) was 
prepared. The mean dexmedetomidine dose of the 
Group D was [66.4 (3.7)] mcg. In Group D, intra 
operative mean heart rate was found to be lower up to 
50 min (P<0.05) and arterial pressure lower up to 30th 
min (P<0.05). NRS values during retrobulbar block 
were lower in Group D [1.9 (0.5)], compared with 
Group C [3.9 (0.6)] (P=0.016). After the 
dexmedetomidine loading dose, intraocular pressure 
(IOP) was significantly decreased [12.3 (1.0) mm Hg] 
compared with preoperative value [16.1 (0.8) mm Hg] 
(P<0.05). Intra operative RSS were higher in Group D 
after the loading dose of dexmedetomidine (P<0.05). 
Incidences of mouth dryness were higher in the Group 
D after surgery (P<0.05), but patient satisfaction was 
also higher (P=0.001). There were no differences in 
Aldrete Scores or surgeon satisfaction scores between 
the groups. This study demonstrates that sedation with 
dexmedetomidine decreases intraocular pressure, pain 
on injection and provides sedation effectively without 
causing respiratory depression. A single dose of 
dexmedetomidine appears to be enough. 
Dexmedetomidine sedation enables full cooperation 
and potentially better operating conditions without 
significant respiratory depression. Apan et al[10] also 
reported that dexmedetomidine made the intra 
operative HR more stable and postoperative pain less 
severe compared with midazolam, thus it was 
appropriate for sedation and analgesia during MAC in 
cataract surgery. This study evaluated the role of α2 
agonist infusion, with dexmedetomidine or midazolam, 
on haemodynamic and respiratory parameters while 
titrating the sedation level with the bispectral index 
(BIS) during cataract surgery. Results showed In 
Group D, heart rate decreased in the later periods of 
surgery (35-50 min) and in the early postoperative 
period (5 (th) and 15 (th) min). Dose adjustments were 
required in six and ten patients in Groups D and M, 
respectively. Pain scores were lower with 
dexmedetomidine infusion. The study concluded that 
dexmedetomidine infusion mildly decreased heart rate 
in the later periods of surgery with better pain scores in 
the postoperative period. Dexmedetomidine should be 
an alternative for intra operative sedation in outpatients 
undergoing cataract surgery. Reetu , Verma et al [11] 
showed that dexmedetomidine and propofol provides 
adequate sedation but the use of propofol is associated 
with more requirements of rescue analgesia and poor 
patient and surgeon satisfaction. Ashraf S et al[12] 
compared both the drugs in paediatric patient during 
Gastrointestinal Endoscopy and concluded that 
dexmedetomidine sedation during Gastrointestinal 
endoscopy provides more safety and heart rate stability 
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presenting itself as a suitable alternative agent 
especially for the relatively longer procedures.  
Studies were also done comparing dexmedetomidine in 
combination with different sedatives Vs various other 
combinations of sedatives. Ashraf Darwish et al[13] 
showed that  both groups provided a similar significant 
reduction in heart rate and mean arterial pressure 
compared with baseline. The oxygen saturation values 
of Dexmedetomodine/Ketamine (DK) group were 
higher than those of Propofol/ Ketamine (PK) group. 
The respiratory rate values of the 
Dexmedetomidine/Ketamine (DK) group were higher 
than those in the Propofol/Ketamine (PK) group. The 
time required to achieve targeted levels of sedation was 
significantly longer in the Dexmedetomidine/ ketamine 
(DK) group. Postoperatively the time to achieve an 
Aldrete score of 10 was higher in Propofol/Ketamine 
(PK) group. Conclusion of study was that 
dexmedetomidine in combination with small dose of 
Ketamine is a valuable adjuvant for sedation in patients 
undergoing DCR surgery and valuable alternative to 
P/K combination. A study conducted by Ozgur Yagan 
et al[14] There was a statistically significant decrease 
in mean arterial pressures following drug 
administration compared to initial measurements in 
both groups. However, there was a statistically 
significant decrease in heart rate only in Group D. 
There was no significant difference between the two 
groups regarding respiratory rate and protection of 
spontaneous respiration. Although the time for Aldrete 
score to be 9 was 16.1 minutes for Group K, it was 
24.9 minutes for Group D, and this difference was 
statistically significant (p<0.01). There was no 
significant difference between the two groups 
regarding adverse effects, pain scores and satisfaction 
levels of the patients and surgeon. The study concludes 
that, ketofol compared to dexmedetomidine, at similar 
sedation levels, is superior agent as it enables 
satisfactory analgesia and has more rapid onset of 
action and shorter recovery periods from anaesthesia 
without causing significant haemodynamic and 
respiratory adverse effects. Dexmedetomidine has been 
used in short or long term sedation in the intensive care 
unit, sedation for various procedures, or as a 
supplementary drug during general anaesthesia.  
Tsai CJ et al [ 15]made a comparison of effectiveness 
of dexmedetomidine Vs propofol target controlled 
infusion for sedation during fibreoptic nasotracheal 
intubation in 40 anticipated difficult airways. 
Dexmedetomidine allows better tolerance, more stable 
haemodynamic states and preserves a patent  airway. 
Nitesh Goel et al [16] Results had shown successful 
intubation in both cases but dexmedetomidine had a 
better outcome with respect to sympathetic response 
and patient tolerance. p value was significant for 
sedation score, pre and post bronchoscopic intubation 
sympathetic response. No episodes of airway 
obstruction and hypoxia were noted with 
dexmedetomidine as compared with propofol. Mean 
Ramsay sedation score was 3.77 as compared to 2.33 
with propofol. The study concludes that 
dexmedetomidine had offered better patient tolerance 
with adequate sedation and preservation of airway as 
compared to propofol and a reduced haemodynamic 
response to intubation.  
Ashraf Darwish et  al [13] comparing  
dexmedetomidine/ketamine with propofol /ketamine 
combination for sedation in patients undergoing 
dacrocystorhinostomy surgery under local anaesthesia 
The conclusion of study was that the two groups gave 
comparable (p>0.05) data in reduction in heart rate, 
Mean arterial pressure with respect to baseline. 
Additionally, the subjective satisfaction score by ISAS 
in group D was higher than that of group P. 
Dexmedetomidine enables the patient to convert easily 
between sedative and cooperative state; therefore, 
cooperative sedation makes patients more comfortable 
during the cataract surgery. Mahfouz A et al [17] 
compared dexmedetomidine with propofol for sedation 
in patients undergoing vitreoretinal surgeries under 
subtenon anaesthesia. This study showed similar 
surgeon satisfaction and higher patient satisfaction 
supporting ISAS scores in the present study with 
significant p value. Shen SL et al[18]  compared 
dexmedetomidine with propofol for conscious sedation 
in awake craniotomy .The conclusions of the study are 
arousal time shorter in group D than P (p<0.001), 
degree of satisfaction in surgeons higher in group D 
(p<0.001),  degree of satisfaction in patients in 2 
groups -no difference (p=0.8) which contrasts with the 
present  study. Reetu Varma et al[ 11] studied both the 
drugs  for MAC in middle ear surgery , made similar 
conclusions supporting the present study, suggested 
that dexmedetomidine provides  good surgeon and 
patient comfort for patients undergoing Tympanoplasty 
under local anaesthesia. When propofol was used, 
immediate interactions with the surgeon did not go 
smoothly due to the patient’s sedated state; however 
inadequate sedation would lead to patient discomfort. 
In this study, we did not check the surgeon's 
satisfaction. However, dexmedetomidine property of 
cooperative sedation may enable the surgeon to 
perform surgery more efficiently. Priyamvada Gupta 
et al[19] studied the safety and efficacy of two 
different doses of dexmedetomidine for sedation and 
analgesia were evaluated. 90 patients were distributed 
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in three groups of 30 each: Dexmedetomidine 0.5 
mcg/kg (DL), dexmedetomidine 1.0 mcg/kg (DH) and 
normal saline (C). Results in groups DL and DH fewer 
patients required supplemental midazolam, 56.7% 
(17/30) and 40% (12/30), compared with control, 
where 86.7% (26/30) needed midazolam supplements. 
P = 0.000. Both groups DL and DH required 
significantly less fentanyl (84.8 and 83.9 μg) versus 
control (144.2 mcg). There was significantly increased 
ease of achieving and maintaining targeted sedation 
and analgesia in both dexmedetomidine groups when 
compared with placebo (P = 0.001). Adverse events 
observed with dexmedetomidine were bradycardia and 
hypotension. They concluded that dexmedetomidine in 
the doses studied was considered safe and effective 
sedative and analgesic for patients undergoing 
procedures under MAC. In contrary to the present 
study results was a prospective single blind, 
randomized study  by Irwin Gratz et al [20] found that 
baseline systolic arterial blood pressure and mean heart 
rate at the end of surgery to baseline in both groups 
showed statistically significant fall in 
dexmedetomidine group compared to the propofol 
group. The study concluded dexmedetomidine is a less 
suitable sedative compared with propofol for use in 
older patients undergoing cataract surgery due to 
decrease in haemodynamic parameters and noted 
increases in complication rates. The reason for these 
contrasting results between this study and the present 
study could be the following: The loading dosage of 
intravenous dexmedetomidine 1 mcg/kg over 10 min 
followed by maintenance intravenous infusion at 0.2 - 
0.7mcg/kg/hr whereas in the present study a loading 
dose was not given , only 0.2 - 0.7mcg/kg/hr infusion 
and even this infusion was titrated to RSS of 3,  
Joung, Kyoung-woon, Choi et al[21] in their study 
comparing effects of dexmedetomidine and propofol 
on Ultrasound guided Radiofrequency Ablation of 
Hepatic neoplasm under MAC. There were significant 
differences in opioid consumption 
(50.1 ± 16.8 ng/kg/min [group D] vs 
71.2 ± 18.7 ng/kg/min [group P]; P = 0.001) and delta 
PaCO2 (10.4 ± 6.4 mm Hg vs 17.2 ± 9.2 mm Hg, 
respectively; P = 0.016). Moreover, respiratory rates 
were significantly different between groups during 
RFA (P < 0.001). However, blood pressure and heart 
rate did not significantly change during 
Radiofrequency ablation. Neither patient nor 
interventional radiologist satisfaction was significantly 
different between groups. Dexmedetomidine provides 
better respiratory stability and reduces opioid 
consumption in comparison with propofol when 
administered under MAC when performing 
Radiofrequency ablation for hepatic neoplasm. In 
conclusion, the present study showed that 
dexmedetomidine seems to be an acceptable agent for 
MAC in outpatients undergoing cataract surgery. 
Compared with propofol, dexmedetomidine reduced 
arterial pressure during the period of operation. 
Satisfaction scores were also in favor of the patients 
treated with dexmedetomidine.  
CONCLUSION 
MAP, HR, RR, SPO2 were compared between the 2 
groups, group P and D at various time points from T1-
T9 were found not to be statistically significant as 
p>0.05. ISAS of group D is 53.50 ±2.193 and ISAS of 
group P is 43.10 ±2.090. The p value between the 2 
study groups is 0.0001 which is highly statistically 
significant. Ramsay sedation scale of 3 was maintained 
throughout the operation in both the study groups. The 
study showed that dexmedetomidine seems to be an 
acceptable agent for MAC compared to propofol in 
patients undergoing cataract surgery. Satisfaction 
scores are also in favor of the patients treated with 
dexmedetomidine based on the p values. 
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